Top Midday Stories: PTC to Be Acquired by Schneider Electric for $23.7 Billion; C.H. Robinson to Acquire RXO for $5.8 Billion
MT newswire2026/10/05 16:0412:04 PM EDT, 10/05/2026 (MT Newswires) -- The S&P 500 Index and Nasdaq Composite were up in late-morning trading Monday, while the Dow Jones Industrial Average was down as Treasury bond yields continued to rise. President Donald Trump is planning to ease limits on the use of dyed red diesel, a tax-exempt variety of the fuel, Bloomberg reported Monday, citing people familiar with the matter. The Trump administration is expected to unveil the plan on Monday, the report said, citing the people. In company news, Schneider Electric said Monday it is acquiring PTC (PTC) in an all-cash deal valued at $23.7 billion. Schneider said it will pay $205 per PTC share, valuing the company's equity at roughly $22.6 billion and representing a premium of 42% to PTC's last closing price. The deal is expected to close by Q3 2027, Schneider said. PTC shares were up 34% near noon. C.H. Robinson Worldwide (CHRW) said Monday it has agreed to acquire RXO (RXO) in a cash-and-stock deal valued at $5.8 billion. Under the terms of the deal, RXO shareholders will receive $17.25 per share in cash and 0.0856 shares of C.H. Robinson common stock for each RXO share they own. RXO shareholders can also choose to receive an all-cash consideration of $30.25 per share or an all-stock consideration of 0.1992 shares of C.H. Robinson stock, the company said. C.H. Robinson shares were down 13.5%, while RXO shares were up 21.1%. SpaceX (SPCX) shares are "cheap and getting cheaper," Morgan Stanley analyst Adam Jonas said Sunday in a note. The shares have hovered around $150 per share since early August, and at $159, investors can take advantage of an opportunity to buy shares that, "while expensive on any trailing metric, look unusually cheap on the forward," Jonas said. SpaceX shares were up 5%. GE HealthCare Technologies (GEHC) said Monday it has entered a definitive agreement to acquire Sofie Biosciences for $945 million in cash. After the deal closes, expected in H1 of 2027, Sofie will become part of GE HealthCare's Pharmaceutical Diagnostics segment,
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Midterm elections expose market vulnerability! AI trading faces rigorous scrutiny, U.S. stock earnings expectations may undergo major adjustments
The results of the US midterm elections and the subsequent market crash have exposed the vulnerability caused by the market’s excessive concentration of bets on artificial intelligence (AI). Investors may need to readjust their expectations for investment returns.

SpaceX unlock wave meets index rebalancing! Goldman Sachs estimates: December rebalancing may bring $10.9 billion in passive buying
The proportion of SpaceX's freely tradable shares has increased from about 5% at the time of its IPO to one-third, and the expansion of index weightings is driving passive funds to increase their holdings. According to Goldman Sachs, the rebalancing of the Russell 1000 Growth Index on December 11 may trigger $10.9 billion in buy orders, with the main counterparts being insiders whose shares are unlocked. The S&P 500 inclusion window points to the second half of 2027, when the competition among passive funds will further intensify.
Citigroup Q3 Holdings: Nvidia (NVDA.US) Remains Top Heavy Position, Expanded Both Index and Tech Stock Options
According to the disclosure by the U.S. Securities and Exchange Commission (SEC), Citigroup (C.US) submitted its third quarter holdings report (13F) as of September 30, 2026, on November 4, 2026.

Carlyle still favors the healthcare sector in Q3, with Medline (MDLN.US) and StandardAero (SARO.US) accounting for over 98% of holdings
Carlyle (CG.US) has submitted its third-quarter holdings report (13F) for the period ending September 30, 2026.
